✦ LIBER ✦

Adjuvant Chemotherapy After Colectomy for Stage III Colon Cancer in the Oldest Old: Trends and Survival Benefits

✍ Scribed by A.A. Abraham; E.B. Habermann; H.M. Parsons; S.M. Vickers; P. Gupta; W.B. Al-Refaie

Book ID: 116706981
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 129 KB
Volume: 165
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2010.11.370

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy for stage III colo

Adjuvant chemotherapy for stage III colon cancer in the oldest old : Results beyond clinical guidelines

✍ Anasooya Abraham; Elizabeth B. Habermann; David A. Rothenberger; Mary Kwaan; Arm 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

Survival after adjuvant 5-FU treatment f

Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer

✍ Wouter H. de Vos tot Nederveen Cappel; Hielke J. Meulenbeld; Jan H. Kleibeuker; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB 👁 2 views

## Abstract __In vitro__ studies suggest that a deficient mismatch repair (MMR) system reduces 5‐Fluorouracil cytotoxicity. Colon cancer (CC) in hereditary nonpolyposis colorectal cancer (HNPCC) is due to a dysfunctioning MMR gene that leads to microsatellite instability (MSI). Clinical studies on

Association between receipt and timing o

Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada

✍ Isac S. F. Lima; Yutaka Yasui; Andrew Scarfe; Marcy Winget 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

Survival benefits and trends in use of a

Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population

✍ Sharon A. Dobie; Joan L. Warren; Barbara Matthews; David Schwartz; Laura-Mae Bal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 1 views

## Abstract ## BACKGROUND This study examined elderly stage II and III rectal cancer patients' adjuvant chemoradiation therapy adherence, trends in adherence over time, and the relation of levels of adherence to mortality. ## METHODS The authors studied 2886 stage II and III rectal cancer patien

3605 Large age and hospital dependent va

3605 Large age and hospital dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in the south of the Netherlands

✍ V.E. Lemmens; L. van Steenbergen; H.J.T. Rutten; G.J. Creemers; J.W.W. Coebergh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB